One Biosciences, a techbio company pioneering clinical-grade single-cell tumor profiling, today announced financial support via a Paris-Saclay Cancer Cluster (PSCC) BOOST grant to develop the first ...
Single-cell RNA sequencing (scRNA-seq) has become an indispensable tool in prostate biology research, considerably advancing our understanding from organ development to disease initiation and ...
Single-cell RNA sequencing (scRNA-seq) provides high-resolution insights into cellular heterogeneity but remains costly, restricting its use to small cohorts that often lack comprehensive clinical ...
7d
Spatial map of bladder cancer reveals hidden tumor environments, new paths toward precision therapy
Researchers at The University of Texas MD Anderson Cancer Center have developed a spatial map of muscle-invasive bladder ...
Why do so many promising drugs fail? This article explores how spatial multiomics reveals hidden cell interactions, helping ...
Researchers at The University of Texas MD Anderson Cancer Center have developed a spatial map of muscle-invasive bladder ...
Trends in liver metastases at diagnosis among young adults with colorectal cancer: A SEER-based analysis, 2010–2022. Genotype-directed targeted therapy combined with HAIC and tislelizumab for ...
A comprehensive review led by Associate Researcher Linnan Zhu and Academician Zemin Zhang at Biomedical Pioneering Innovation ...
Spatial analyses uncovered how different tumor regions interact with immune cells and respond to therapies, offering a new ...
The single-cell genomics industry does not stop advancing, with a steady stream of new companies, kits, acquisitions, and more. One new company, ArgenTag, was founded in Argentina during the COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results